कृपया अन्य खोज का प्रयास करें
NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Yoram Drucker | 58 | 2022 | Co-Founder, VP of Strategic Development & Chairman |
Michael Belkin | 82 | - | Member of Scientific Advisory Board |
Gabriel Zeilig | - | - | Member of Scientific Advisory Board |
Gadi Riesenfeld | - | 2023 | Independent Director |
Teodoro Forcht Dagi | 74 | 2023 | Member of Scientific Advisory Board |
Shulamit Levenberg | 61 | - | Co-Founder & Member of Scientific Advisory Board |
James A. Richardson | 79 | 2011 | Independent Director |
Daniel Offen | - | - | Co-Founder & Member of Scientific Advisory Board |
Nahshon Knoller | - | 2024 | Head of the neurosurgery department at Shiba & Member of Scientific Advisory Board |
Oded Orgil | 56 | 2022 | Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है